Pharmaceuticals

Latest Kaiser Health News Stories

KHN’s ‘What the Health?’: SCOTUS, Trump Collide Over Transgender Rights

KHN Original

The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.

Must-Reads Of The Week

KHN Original

KHN executive editor Damon Darlin wades through mounds of health care policy stories — so you don’t have to.

Listen: A New Hope In The Battle Against COVID-19

KHN Original

KHN’s Julie Rovner joins a panel of journalists on “1A” to talk about promising results in a study of the drug remdesivir and other developments in the battle against the coronavirus.

KHN’s ‘What The Health?’: SCOTUS Decides An ACA Case. No, Not THAT Case.

KHN Original

The Supreme Court this week, in an 8-1 decision, ruled that insurers are due the roughly $12 billion that Congress several years ago tried to cut off in payments under the Affordable Care Act’s “risk corridors” provision. And while the COVID-19 pandemic continues to rage in many places around the country, states are starting to reopen their economies at the urging of President Donald Trump and over objections of public health officials. Caitlin Owens of Axios and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Carmen Heredia Rodriguez, who wrote the latest KHN-NPR “Bill of the Month” installment about COVID testing that should have been free but was not.

KHN’s ‘What The Health?’: How Will We Reopen The Economy?

KHN Original

The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’

KHN Original

The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.